Coagulation Conundrum Roundtable: Case-based Discussion on the Implications of Exogenous Estrogens in Hemostasis and Thrombosis
Women of childbearing age with either a congenital bleeding disorder or thrombophilia are faced with several health problems related to hemostasis and thrombosis. These include heavy menstrual bleeding and postpartum hemorrhage in women with congenital bleeding disorders, and an increased risk of thrombosis while using exogenous estrogens in women with congenital thrombophilia. In this session, two clinical experts will discuss such scenario’s in two patients, and will focus on the following questions: • How Do You Manage Contraception and Pregnancy in Patients with Congenital Bleeding Disorders?
• IVF and Thrombophilia: Should We Anticoagulate?
Although clinical data are limited and randomized trials are rare, for each of these scenarios both speakers shall provide the most current data and treatment guidelines, identifying gaps and future approaches to management.
Dr. Audra James will provide the Obstetricians View on each scenario.
Dr. Margaret Ragni will provide the Hematologists View on each scenario
Active, International, Emeritus, and Honorary Members
Associate, International Associate, Student, and Resident Members